GENI Strangle Strategy
GENI (Genius Sports Limited), in the Communication Services sector, (Internet Content & Information industry), listed on NYSE.
Genius Sports Limited develops and sells technology-led products and services to the sports, sports betting, and sports media industries. It offers technology infrastructure for the collection, integration, and distribution of live data of sports leagues; streaming solutions comprising technology, automatic production, and distribution for sports to commercialize video footage of their games; and end-to-end integrity services to sports leagues, such as full-time active monitoring technology, which uses mathematical algorithms to identify and flag suspicious betting activity in global betting markets, as well as a full suite of online and offline educational and consultancy services. The company also provides live sports data collection; pre-game and in-game odds feeds; risk management services, including customer profiling, monitoring of incoming bets, automated acceptance and rejection of bets, and limit setting; live streaming services; creation, delivery, and measurement services for personalized online marketing campaigns; and fan engagement widgets for digital publishers that offer live game statistics and betting-related content. The company is headquartered in London, the United Kingdom.
GENI (Genius Sports Limited) trades in the Communication Services sector, specifically Internet Content & Information, with a market capitalization of approximately $1.08B, a beta of 1.80 versus the broader market, a 52-week range of 3.825-13.73, average daily share volume of 5.8M, a public-listing history dating back to 2020, approximately 2K full-time employees. These structural characteristics shape how GENI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.80 indicates GENI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on GENI?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current GENI snapshot
As of May 15, 2026, spot at $4.26, ATM IV 75.90%, IV rank 30.12%, expected move 21.76%. The strangle on GENI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on GENI specifically: GENI IV at 75.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 21.76% (roughly $0.93 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GENI expiries trade a higher absolute premium for lower per-day decay. Position sizing on GENI should anchor to the underlying notional of $4.26 per share and to the trader's directional view on GENI stock.
GENI strangle setup
The GENI strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GENI near $4.26, the first option leg uses a $4.47 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GENI chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GENI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $4.47 | N/A |
| Buy 1 | Put | $4.05 | N/A |
GENI strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
GENI strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on GENI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on GENI
Strangles on GENI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GENI chain.
GENI thesis for this strangle
The market-implied 1-standard-deviation range for GENI extends from approximately $3.33 on the downside to $5.19 on the upside. A GENI long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current GENI IV rank near 30.12% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on GENI should anchor more to the directional view and the expected-move geometry. As a Communication Services name, GENI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GENI-specific events.
GENI strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GENI positions also carry Communication Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GENI alongside the broader basket even when GENI-specific fundamentals are unchanged. Always rebuild the position from current GENI chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on GENI?
- A strangle on GENI is the strangle strategy applied to GENI (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With GENI stock trading near $4.26, the strikes shown on this page are snapped to the nearest listed GENI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GENI strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the GENI strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 75.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GENI strangle?
- The breakeven for the GENI strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GENI market-implied 1-standard-deviation expected move is approximately 21.76%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on GENI?
- Strangles on GENI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GENI chain.
- How does current GENI implied volatility affect this strangle?
- GENI ATM IV is at 75.90% with IV rank near 30.12%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.